{"id":"https://openalex.org/W2969985260","doi":"https://doi.org/10.1186/s40425-019-0711-0","title":"Concurrent therapy with immune checkpoint inhibitors and TNF\u03b1 blockade in patients with gastrointestinal immune-related adverse events","display_name":"Concurrent therapy with immune checkpoint inhibitors and TNF\u03b1 blockade in patients with gastrointestinal immune-related adverse events","alternate_titles":[],"publication_year":2019,"publication_date":"2019-08-22","ids":{"openalex":"https://openalex.org/W2969985260","doi":"https://doi.org/10.1186/s40425-019-0711-0","mag":"2969985260","pmid":"https://pubmed.ncbi.nlm.nih.gov/31439050","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6704680"},"language":"en","primary_location":{"id":"doi:10.1186/s40425-019-0711-0","doi":"https://doi.org/10.1186/s40425-019-0711-0","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40425-019-0711-0","pdf_url":"https://jitc.bmj.com/content/jitc/7/1/226.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2969985260"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/7/1/226.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087354897","display_name":"Yousef R. Badran","orcid":"https://orcid.org/0009-0009-4463-5693","observed_orcids":["https://orcid.org/0009-0009-4463-5693"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yousef R. Badran","raw_affiliation_strings":["Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA","Harvard Medical School, Boston, MA, 02115, USA","Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA, 02115, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046320640","display_name":"Justine Vanessa Cohen","orcid":"https://orcid.org/0000-0003-4803-9230","observed_orcids":["https://orcid.org/0000-0003-4803-9230"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Justine V. Cohen","raw_affiliation_strings":["Division of Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA","Harvard Medical School, Boston, MA, 02115, USA","Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA, 02115, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015428519","display_name":"Priscilla Kaliopi Brastianos","orcid":"https://orcid.org/0000-0003-4470-8425","observed_orcids":["https://orcid.org/0000-0003-4470-8425"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Priscilla K. Brastianos","raw_affiliation_strings":["Division of Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA","Harvard Medical School, Boston, MA, 02115, USA","Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA, 02115, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034115525","display_name":"Aparna R. Parikh","orcid":"https://orcid.org/0000-0002-5245-7841","observed_orcids":["https://orcid.org/0000-0002-5245-7841"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aparna R. Parikh","raw_affiliation_strings":["Division of Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA","Harvard Medical School, Boston, MA, 02115, USA","Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA, 02115, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044225007","display_name":"Theodore Sunki Hong","orcid":"https://orcid.org/0000-0001-8481-6581","observed_orcids":["https://orcid.org/0000-0001-8481-6581"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Theodore S. Hong","raw_affiliation_strings":["Department of Radiation Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA","Harvard Medical School, Boston, MA, 02115, USA","Massachusetts General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA, 02115, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043698578","display_name":"Michael Lawrence Dougan","orcid":"https://orcid.org/0000-0001-9266-2009","observed_orcids":["https://orcid.org/0000-0001-9266-2009"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Michael Dougan","raw_affiliation_strings":["Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA. mldougan@partners.org","Harvard Medical School, Boston, MA, 02115, USA. mldougan@partners.org","Massachusetts General Hospital"],"raw_orcid":"https://orcid.org/0000-0001-9266-2009","affiliations":[{"raw_affiliation_string":"Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA. mldougan@partners.org","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"Harvard Medical School, Boston, MA, 02115, USA. mldougan@partners.org","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Massachusetts General Hospital","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5043698578"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":7.2037,"has_fulltext":true,"cited_by_count":150,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.981703,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"7","issue":"1","first_page":"226","last_page":"226"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8989999890327454},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.7929999828338623},{"id":"https://openalex.org/keywords/tnf-alpha-blockade","display_name":"TNF-alpha blockade","score":0.7860000133514404},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9670000076293945},{"id":"https://openalex.org/keywords/concurrent-immunotherapy","display_name":"concurrent immunotherapy","score":0.7379999756813049},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.8370000123977661},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cemiplimab","display_name":"cemiplimab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/corticosteroid-tapering","display_name":"corticosteroid tapering","score":0.8790000081062317},{"id":"https://openalex.org/keywords/gastrointestinal-inflammation","display_name":"gastrointestinal inflammation","score":0.6499999761581421},{"id":"https://openalex.org/keywords/endoscopic-findings","display_name":"endoscopic findings","score":0.4059999883174896}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.924830436706543},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.9011436700820923},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.7399622797966003},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.7354835271835327},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6253325939178467},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.623705267906189},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.576890230178833},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.525714099407196},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5028688311576843},{"id":"https://openalex.org/C2775862500","wikidata":"https://www.wikidata.org/wiki/Q2453464","display_name":"Colitis","level":2,"score":0.45533671975135803},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.44576138257980347},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.44005727767944336},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3940984904766083},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.37386488914489746},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27945464849472046},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2653515934944153}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005767","descriptor_name":"Gastrointestinal Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1186/s40425-019-0711-0","doi":"https://doi.org/10.1186/s40425-019-0711-0","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40425-019-0711-0","pdf_url":"https://jitc.bmj.com/content/jitc/7/1/226.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6704680","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6704680/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Immunother Cancer","raw_type":"Text"},{"id":"pmid:31439050","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31439050","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for immunotherapy of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:ae884ff9b7cc4b2d974df164047ca086","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/ae884ff9b7cc4b2d974df164047ca086","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s40425-019-0711-0","doi":"https://doi.org/10.1186/s40425-019-0711-0","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40425-019-0711-0","pdf_url":"https://jitc.bmj.com/content/jitc/7/1/226.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[{"id":"https://openalex.org/G898593530","display_name":"Regulation of brown fat metabolism by the immune receptor PD-L1","funder_award_id":"K08DK114563","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"}],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320311351","display_name":"American Gastroenterological Association","ror":"https://ror.org/00y65x556"},{"id":"https://openalex.org/F4320319264","display_name":"MacroGenics","ror":"https://ror.org/01hcd4187"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320330502","display_name":"Plexxikon","ror":"https://ror.org/00qk1xk35"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320334461","display_name":"Foundation Medicine","ror":"https://ror.org/02ackr434"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2969985260.pdf","grobid_xml":"https://content.openalex.org/works/W2969985260.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1996049617","https://openalex.org/W2023809975","https://openalex.org/W2087115854","https://openalex.org/W2292645700","https://openalex.org/W2347141054","https://openalex.org/W2525217971","https://openalex.org/W2585427084","https://openalex.org/W2622111008","https://openalex.org/W2736166064","https://openalex.org/W2750254726","https://openalex.org/W2768429453","https://openalex.org/W2769767397","https://openalex.org/W2779658193","https://openalex.org/W2782898385","https://openalex.org/W2783137027","https://openalex.org/W2789465165","https://openalex.org/W2791483720","https://openalex.org/W2804191059","https://openalex.org/W2805482047","https://openalex.org/W2887577080","https://openalex.org/W2888695906","https://openalex.org/W2894717949","https://openalex.org/W2897516580","https://openalex.org/W2899537551","https://openalex.org/W2917155973","https://openalex.org/W2931644395","https://openalex.org/W2937479113","https://openalex.org/W2943218134","https://openalex.org/W2943668434","https://openalex.org/W2958582726","https://openalex.org/W2999042597","https://openalex.org/W4406660574"],"related_works":["https://openalex.org/W2987140933","https://openalex.org/W3134029116","https://openalex.org/W3104677207","https://openalex.org/W3097089513","https://openalex.org/W4381716038","https://openalex.org/W3094333395","https://openalex.org/W3201638432","https://openalex.org/W4376225728","https://openalex.org/W2943218134","https://openalex.org/W4403722165"],"abstract_inverted_index":{"BACKGROUND:":[0],"Immune":[1,27],"checkpoint":[2],"inhibitors":[3],"(ICI)":[4],"have":[5,51,60],"demonstrated":[6,168],"remarkable":[7],"efficacy":[8],"as":[9,183],"cancer":[10,200,232],"therapeutics,":[11],"however,":[12],"their":[13,142],"use":[14,191],"remains":[15],"limited":[16],"due":[17],"to":[18,39,54,242,256],"the":[19,33,40,92,95,176,258],"development":[20],"of":[21,42,45,97,141,152,171,194,199,218,224,260],"immune":[22],"related":[23,28],"adverse":[24],"events":[25],"(irAEs).":[26],"enterocolitis":[29],"(irEC)":[30],"is":[31],"among":[32],"most":[34],"common":[35],"severe":[36],"irAEs":[37],"leading":[38],"discontinuation":[41],"ICIs.":[43,109],"Inhibitors":[44],"tumor":[46,70],"necrosis":[47],"factor":[48],"alpha":[49],"(anti-TNF\u03b1)":[50],"been":[52,81],"used":[53,182],"treat":[55],"irEC.":[56,250],"Recent":[57],"animal":[58],"studies":[59],"shown":[61],"that":[62],"concurrent":[63],"treatment":[64,236,262],"with":[65,103,114,120,149,206,215,237],"anti-TNF\u03b1":[66,104,238],"and":[67,72,105,154,158,192,208,227,239,248],"ICIs":[68],"improves":[69],"responses":[71],"decreases":[73],"colitis":[74],"severity.":[75],"This":[76],"approach":[77],"has":[78],"not":[79],"yet":[80],"studied":[82],"in":[83,86],"prospective":[84],"trials":[85,253],"humans.":[87],"Here":[88],"we":[89],"describe,":[90],"for":[91],"first":[93,143,184],"time,":[94],"outcomes":[96,259],"patients":[98,113,135,147,202],"who":[99],"were":[100,118,203],"treated":[101,119,204],"concurrently":[102,205],"one":[106],"or":[107,130],"two":[108],"CASE":[110],"PRESENTATIONS:":[111],"Five":[112],"different":[115],"primary":[116],"malignancies":[117],"ipilimumab/nivolumab":[121],"(2":[122],"patients),":[123],"pembrolizumab":[124],"(1":[125,128,132],"patient),":[126,129],"ipilimumab":[127],"cemiplimab":[131],"patient).":[133],"All":[134],"developed":[136],"irEC":[137],"within":[138],"40":[139],"days":[140],"ICI":[144,213,240],"dose.":[145],"The":[146],"presented":[148],"a":[150,169],"combination":[151],"upper":[153,161],"lower":[155,164],"gastrointestinal":[156,177,195],"symptoms":[157],"subsequently":[159],"underwent":[160],"endoscopy":[162],"and/or":[163],"endoscopy.":[165],"Endoscopy":[166],"results":[167],"spectrum":[170],"acute":[172,225],"inflammatory":[173],"changes":[174],"across":[175],"tract.":[178],"Steroid":[179],"therapy":[180,214],"was":[181],"line":[185],"treatment.":[186],"To":[187],"prevent":[188],"prolonged":[189],"steroid":[190,246],"recurrence":[193,217],"inflammation":[196,226],"after":[197],"resumption":[198],"therapy,":[201],"infliximab":[207],"ICI.":[209],"Patients":[210],"tolerated":[211],"further":[212],"no":[216,231],"symptoms.":[219],"Repeat":[220],"endoscopies":[221],"showed":[222,230],"resolution":[223],"restaging":[228],"imaging":[229],"progression.":[233],"CONCLUSIONS:":[234],"Concurrent":[235],"appears":[241],"be":[243],"safe,":[244],"facilitates":[245],"tapering,":[247],"prevents":[249],"Prospective":[251],"clinical":[252],"are":[254],"needed":[255],"assess":[257],"this":[261],"modality.":[263]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2969985260","counts_by_year":[{"year":2026,"cited_by_count":15},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":23},{"year":2023,"cited_by_count":26},{"year":2022,"cited_by_count":21},{"year":2021,"cited_by_count":25},{"year":2020,"cited_by_count":22},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2019-08-29T00:00:00"}
